Ebola

The New England Journal of Medicine
Heinz FeldmannThomas W Geisbert

Abstract

No abstract listed.

References

Dec 22, 1967·Deutsche medizinische Wochenschrift·R SiegertG Müller
Jan 1, 1982·Intervirology·M P KileyH Wulff
Nov 22, 2008·PLoS Pathogens·Jonathan S TownerStuart T Nichol
Jul 11, 2009·Science·Roger W BarretteMichael T McIntosh
Aug 4, 2009·PLoS Pathogens·Jonathan S TownerPierre E Rollin
Nov 1, 2011·PLoS Pathogens·Ana NegredoAntonio Tenorio
Aug 24, 2012·Journal of Virology·Thomas HoenenHeinz Feldmann
Sep 22, 2012·Archives of Virology·Yangyang PanQiaoying Zeng
Apr 22, 2014·Viruses·Kevin J Olival, David T S Hayman
Oct 10, 2014·The Journal of Pathology·Roosecelis Brasil MartinesSherif R Zaki
May 30, 2015·Cell Death and Differentiation·L FalascaM Piacentini
Sep 1, 2015·Disaster Medicine and Public Health Preparedness·Aitor CocaRonald Shaffer
Jan 7, 2016·The New England Journal of Medicine·Johan van GriensvenUNKNOWN Ebola-Tx Consortium
Jan 28, 2016·Emerging Infectious Diseases·Emmie de WitVincent J Munster
Feb 4, 2016·Nature·Joshua QuickMiles W Carroll
Feb 18, 2016·The New England Journal of Medicine·Timothy M UyekiUNKNOWN Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and E
Apr 20, 2016·PLoS Medicine·Jake DunningUNKNOWN RAPIDE-TKM trial team
Jul 2, 2016·The Journal of Infectious Diseases·Philippe Guillaume PoliquinJames E Strong
Jul 23, 2016·The Journal of Infectious Diseases·Pauline VetterLaurent Kaiser
Jul 30, 2016·Critical Care : the Official Journal of the Critical Care Forum·Aleksandra LeligdowiczRobert A Fowler
Aug 31, 2016·Nature Microbiology·Armand SprecherMichel Van Herp
Oct 30, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Boubacar DialloSophie Duraffour
Oct 13, 2016·The New England Journal of Medicine·UNKNOWN PREVAIL II Writing GroupDenis Malvy
Oct 28, 2016·PLoS Neglected Tropical Diseases·Robert J ShortenStephen Mepham
Nov 16, 2016·PLoS Medicine·UNKNOWN International Ebola Response TeamZabulon Yoti
Nov 27, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M S CherifN Magassouba
Dec 14, 2016·Annual Review of Pathology·Laura BaselerDavid M Morens
Jan 10, 2017·MSphere·Diego CantoniJeremy S Rossman
Jan 24, 2017·Nature Reviews. Immunology·Joseph B PrescottSonja M Best
Apr 12, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A WilkinsonM Leach
Apr 26, 2017·Critical Reviews in Microbiology·Chad T CoarseyWaseem Asghar
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Soushieta JagadeshJanet T Scott
Oct 12, 2017·The New England Journal of Medicine·Stephen B KennedyUNKNOWN PREVAIL I Study Group
Oct 14, 2017·African Health Sciences·Shrivastava Saurabh, Shrivastava Prateek
Jan 30, 2018·Nature Reviews. Drug Discovery·Robert W CrossThomas W Geisbert
Mar 20, 2018·Advances in Virus Research·Jackson EmanuelHeinz Feldmann
Apr 6, 2018·Nature·Mang ShiYong-Zhen Zhang
Jul 10, 2018·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Lise GrossRodolphe Thiebaut
Jul 28, 2018·The Lancet Infectious Diseases·Emily Kainne DokuboMosoka P Fallah
Aug 23, 2018·The New England Journal of Medicine·Vincent J MunsterJean-Vivien Mombouli
Aug 29, 2018·Nature Microbiology·Tracey GoldsteinJonna A K Mazet

❮ Previous
Next ❯

Citations

Sep 24, 2020·The New England Journal of Medicine·Athalia ChristieRobert R Redfield
Oct 6, 2020·Frontiers in Immunology·Maria TrovatoPiergiuseppe De Berardinis
Aug 5, 2020·Journal of Public Health Policy·Phillip M SingerScott L Greer
Dec 11, 2020·Antiviral Chemistry & Chemotherapy·Johanna Huchting
Mar 19, 2021·Virulence·Satoko Yamaoka, Hideki Ebihara
Apr 7, 2021·Nature Medicine·Daniel G Bausch
Apr 9, 2021·Science Translational Medicine·Cassio M FontesAshutosh Chilkoti
Jul 8, 2020·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Olivier Garraud
Jul 1, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Joanna NowakowskaPiotr Rzymski
Jul 31, 2021·Current Opinion in Pharmacology·Ashish Ranjan SharmaSang-Soo Lee
Aug 24, 2021·Current Opinion in Pharmacology·Goutam BanerjeePratik Banerjee
Sep 1, 2021·Current Opinion in Pharmacology·Chiranjib Chakraborty
Nov 19, 2021·The Journal of Infectious Diseases·Hugues Fausther-BovendoGary P Kobinger
Jan 25, 2022·Disease Models & Mechanisms·Spyridon MakrisSophie E Acton

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Pediatric Infectious Disease Journal
Robert J Leggiadro
Nursing Times
M Gelbart
The American Journal of Nursing
Nancy Sharts-Hopko
Nursing
Kristopher T Starr
Journal of Business Continuity & Emergency Planning
Lyndon Bird
© 2022 Meta ULC. All rights reserved